Health Law Daily Wrap Up, MEDICAL DEVICES—NOTICES: EUA for ExThera Medical Corporation Seraph 100 Microbind Affinity Blood Filter revoked, (Feb 24, 2026)

By WK Editorial Staff

The FDA determined that it is appropriate to protect the public health or safety to revoke this Authorization.

The FDA revoked the Emergency Use Authorization (EUA) (the Authorization) issued to ExThera Medical Corporation, for the Seraph 100 Microbind Affinity Blood Filter (Seraph 100). The FDA revoked the Authorization under the Federal Food, Drug, and Cosmetic Act (FDC Act) as requested by the Authorization holder. ExThera Medical Corporation notified the FDA that as of the date of the revocation, no viable Seraph 100 Microbind Affinity Blood Filter (Seraph 100) remained under EUA (Notice, 91 Fed. Reg. 8008 (Feb. 19, 2026)).

Dates. The revocation of the Authorization for the ExThera Medical Corporation Seraph 100 Microbind Affinity Blood Filter (Seraph 100) is effective as of November 24, 2025.

FederalRegisterIssuances: Notices FDCActNews MDeviceNews SafetyNews